1h Free Analyst Time
The companion animal specialty drugs market is forecasted to grow by USD 6.54 billion during 2024-2029, accelerating at a CAGR of 7.4% during the forecast period. The report on the companion animal specialty drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increase in pet humanization, rising awareness about disease prevention and pet insurance, and rise in aging companion animal population.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The companion animal specialty drugs market is segmented as below:
By Distribution Channel
- Veterinary hospitals
- Pet care clinics
- Pharmacy stores
By Product
- Vaccines
- Antibiotics
- Parasiticides
- Feed additives
- Others
By Route Of Administration
- Oral
- Injectable
By Animal Type
- Cats
- Dogs
- Horses
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the companion animal specialty drugs market covers the following areas:
- Companion Animal Specialty Drugs Market sizing
- Companion Animal Specialty Drugs Market forecast
- Companion Animal Specialty Drugs Market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by Distribution Channel
9 Market Segmentation by Product
10 Market Segmentation by Route of Administration
11 Market Segmentation by Animal Type
12 Customer Landscape
13 Geographic Landscape
14 Drivers, Challenges, and Opportunity/Restraints
15 Competitive Landscape
16 Competitive Analysis
17 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global companion animal specialty drugs market: Bayer AG, Beaphar Beheer BV, Bimeda Holdings Ltd., Boehringer Ingelheim International GmbH, Ceva Sante Animale, Chanelle Pharma Group, Dechra Pharmaceuticals Plc, Elanco Animal Health Inc., Kyoritsuseiyaku Corp., LABORATORIOS CALIER S.A, Mars Inc., Merck and Co. Inc., Neogen Corp., Norbrook Laboratories Ltd., Orion Corp., Tianjin ringpu bio-technology Co. Ltd., Vetoquinol SA, Virbac Group, Zenex Animal Health India Private Ltd., and Zoetis Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is enhanced companion animal specialty drug offerings."
According to the report, one of the major drivers for this market is the increase in pet humanization.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Bayer AG
- Beaphar Beheer BV
- Bimeda Holdings Ltd.
- Boehringer Ingelheim International GmbH
- Ceva Sante Animale
- Chanelle Pharma Group
- Dechra Pharmaceuticals Plc
- Elanco Animal Health Inc.
- Kyoritsuseiyaku Corp.
- LABORATORIOS CALIER S.A
- Mars Inc.
- Merck and Co. Inc.
- Neogen Corp.
- Norbrook Laboratories Ltd.
- Orion Corp.
- Tianjin ringpu bio-technology Co. Ltd.
- Vetoquinol SA
- Virbac Group
- Zenex Animal Health India Private Ltd.
- Zoetis Inc.